Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123971
Published online Nov 15, 2026. doi: 10.4251/wjgo.123971
Published online Nov 15, 2026. doi: 10.4251/wjgo.123971
Table 1 Demographic and clinical characteristics of the study population
| Variable | Patient cohorts (n = 125) |
| Gender | |
| Female | 56 |
| Male | 69 |
| Age of onset (months) | |
| 0-2 | 54 |
| 2-4 | 35 |
| 4-6 | 10 |
| 6-12 | 16 |
| 12-24 | 3 |
| 24-36 | 5 |
| > 36 | 2 |
| Weight (kg) | 6.44 ± 2.46 (1.67-14.00) |
| Thyroid function | |
| Normal | 104 |
| Abnormal | 21 |
| Gene | |
| HOM | 83 |
| HET | 25 |
| Compound HET | 17 |
| Ethnic group | |
| Han Chinese | 73 |
| China’s ethnic minorities | 52 |
| Region (Yunnan Province) | |
| Kunming city | 49 |
| Other regions | 76 |
Table 2 Comparison of the serum biochemical indices among the paediatric groups
| Indices | Reference ranges | Paediatric patients | P value | ||
| (0-2 months), n = 54 | (2-4 months), n = 35 | (> 4 months), n = 36 | |||
| TBA | 0-15 µmol/L | 178.8 ± 60.87a | 128.54 ± 81.26b | 141.15 ± 77.92 | a vs b, P = 0.0002 |
| TBIL | 0-26 µmol/L | 84.08 ± 67.86a | 43.41 ± 46.8b | 9.28 ± 4.22c | a vs b, P = 0.0030; b vs c, P < 0.0001; a vs c, P < 0.0001 |
| IBIL | 0-14 µmol/L | 63.49 ± 57.21a | 33.87 ± 44.37b | 5.71 ± 3.3c | a vs b, P = 0.0122; b vs c, P < 0.0001; a vs c, P = 0.0004 |
| GGT | 5-19 U/L | 128.53 ± 112.17a | 87.2 ± 127.38b | 22.57 ± 30.45c | a vs c, P < 0.0001; b vs c, P = 0.0054 |
| ALP | 146-500 U/L | 425.48 ± 157.45a | 343.93 ± 133.28b | 261.16 ± 93.14c | a vs b, P = 0.0148; b vs c, P = 0.0041; a vs c, P < 0.0001 |
| DBIL | 0-10 µmol/L | 20.74 ± 38.75 | 9.54 ± 11.28 | 4.14 ± 3.35 | NS |
| ALT | 7-30 U/L | 37.50 ± 29.95 | 42.44 ± 48.95 | 40.69 ± 39.15 | NS |
| AST | 14-44 U/L | 64.24 ± 54.81 | 64.44 ± 54.09 | 56.17 ± 22.54 | NS |
| AFP | < 200 µg/L | 5472.47 ± 12515.0 | 1515.87 ± 2992.81 | 72.72 ± 183.27 | NS |
| Vit A | 1.05-2.8 µmol/L | 1.467 ± 0.55 | 1.79 ± 0.73 | 2.00 ± 0.58 | NS |
| Vit D | 50-147 nmol/L | 79.60 ± 34.71 | 97.75 ± 37.55 | 122.52 ± 35.44 | NS |
| Vit E | 16.25-33.5 µmol/L | 26.25 ± 8.19 | 29.0 ± 7.01 | 29.23 ± 7.14 | NS |
| Zinc | 3.7-7.3 mg/L | 3.91 ± 0.59 | 3.47 ± 0.9 | 4.33 ± 0.49 | NS |
| Fe | 373.5-557.2 mg/L | 399.35 ± 30.26 | 631.93 ± 890.43 | 409.24 ± 32.72 | NS |
Table 3 Spectrum of homozygous, heterozygous, and compound heterozygous variants in 125 affected individuals
| Father | Mother | ACMG classification | |
| Proband (n = 17) | Compound heterozygous | ||
| c.800C>T, c.185C>T | c.800C>T | c.800C>T, c.185C>T | c.185C>T: VUS |
| c.800C>T, c.944-32G>C | c.944-32G>C | c.800C>T | c.944-32G>C: VUS |
| c.800C>T, c.944-32G>C | c.800C>T | c.944-32G>C | c.944-32G>C: VUS |
| c.800C>T, c.263T>C | c.263T>C | c.800C>T | c.944-32G>C: VUS |
| c.800C>T, c.682_683del | c.682_683del | c.800C>T | c.682_683del: LP |
| c.799T>C, c.800C>T | c.800C>T | c.799T>C | c.799T>C: VUS |
| c.800C>T, c.263T>C | c.800C>T | c.263T>C | c.263T>C: P |
| c.800C>T, c.54delT | c.800C>T | c.54delT | c.54delT: LP |
| c.800C>T, c.54delT | c.800C>T | c.54delT | c.54delT: LP |
| c.800C>T, c.402G>A | c.800C>T | c.800C>T, c.402G>A | c.402G>A: VUS |
| c.422dupA, c.800C>T | c.800C>T | c.422dupA | c.422dupA: VUS |
| c.422dupA, c.800C>T | c.800C>T | c.422dupA | c.422dupA: VUS |
| c.997G>A, c.800C>T | c.997G>A, c.800C>T | c.800C>T | c.997G>A: VUS |
| c.997G>A, c.800C>T | c.997G>A, c.800C>T | c.800C>T | c.997G>A: VUS |
| c.800C>T, c.54del | c.54del | c.800C>T | c.54del: LP |
| c.800C>T, c.263T>C | c.800C>T | c.263T>C | c.263T>C: P |
| c.800C>T, c.413T>C | c.800C>T, c.413T>C | c.800C>T | c.413T>C: VUS |
| Proband (n = 25) | Heterozygous | ||
| c.800C>T | c.800C>T | c.800C>T: P | |
| c.800C>T | c.800C>T | ||
| c.263T>C | c.263T>C | c.263T>C: P | |
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.745C>T | c.745C>T | c.745C>T: VUS | |
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| c.800C>T | c.800C>T | ||
| Proband (n = 83) | homozygous | ||
| c.800C>T | c.800C>T | c.800C>T | c.800C>T: P |
Table 4 Multivariable-adjusted associations between gene variants and serum biochemical indices in 84 pediatric participants
| Model 1 | Model 2 | Model 3 | |||||||
| Characteristic | Beta | 95%CI | P value | Beta | 95%CI | P value | Beta | 95%CI | P value |
| Gene | TBA | ||||||||
| 1 | 82 | 31-132 | 0.002 | 83 | 31-134 | 0.002 | 86 | 26-147 | 0.007 |
| 2 | -2.0 | -58 to 54 | > 0.9 | -2.1 | -59 to 55 | > 0.9 | -6.1 | -72 to 60 | 0.9 |
| 3 | 95 | 36-155 | 0.002 | 95 | 35-155 | 0.003 | 95 | 23-166 | 0.011 |
| GGT | |||||||||
| 1 | -182 | -284 to -80 | < 0.001 | -176 | -279 to -73 | 0.001 | -253 | -380 to -125 | < 0.001 |
| 2 | -189 | -302 to -76 | 0.002 | -189 | -303 to -76 | 0.002 | -255 | -394 to -116 | < 0.001 |
| 3 | -149 | -269 to -29 | 0.017 | -149 | -270 to -29 | 0.017 | -244 | -393 to -95 | 0.002 |
| AFP | |||||||||
| 1 | 800 | -4142 to 5741 | 0.8 | 1294 | -3717 to 6305 | 0.6 | 490 | -7846 to 8826 | > 0.9 |
| 2 | -441 | -5886 to 5004 | 0.9 | -447 | -5883 to 4988 | 0.9 | -1149 | -9866 to 7568 | 0.8 |
| 3 | 6,416 | 207-12624 | 0.048 | 6349 | 150-12547 | 0.050 | 5334 | -350 to 14619 | 0.3 |
| Vit D | |||||||||
| 1 | -24 | -56 to 7.6 | 0.14 | -27 | -59 to 5.1 | 0.10 | -18 | -55 to 19 | 0.4 |
| 2 | -4.1 | -40 to 32 | 0.8 | -4.0 | -39 to 32 | 0.8 | -0.91 | -41 to 40 | > 0.9 |
| 3 | -43 | -81 to -3.7 | 0.035 | -42 | -81 to -3.8 | 0.035 | -35 | -80 to 10 | 0.13 |
| Vit E | |||||||||
| 1 | -13 | -19 to -7.5 | < 0.001 | -13 | -19 to -7.4 | < 0.001 | -15 | -22 to -8.1 | < 0.001 |
| 2 | -7.8 | -14 to -1.5 | 0.018 | -7.8 | -14 to -1.4 | 0.019 | -9.3 | -17 to -1.9 | 0.017 |
| 3 | -14 | -23 to -6.1 | 0.001 | -14 | -23 to -6.0 | 0.001 | -16 | -25 to -6.6 | 0.002 |
Table 5 Logistic-regression associations between gene variants and thyroid dysfunction in 84 pediatric participants
| Model 1 | Model 2 | Model 3 | |||||||
| Characteristic | OR | 95%CI | P value | OR | 95%CI | P value | OR | 95%CI | P value |
| Gene | |||||||||
| 1 | 0.07 | 0.01-0.42 | 0.006 | 0.07 | 0.01-0.45 | 0.007 | 0.14 | 0.01-1.58 | 0.12 |
| 2 | 0.17 | 0.02-1.18 | 0.085 | 0.17 | 0.02-1.33 | 0.10 | 0.42 | 0.03-5.62 | 0.5 |
| 3 | 0.11 | 0.01-0.96 | 0.060 | 0.11 | 0.01-0.96 | 0.060 | 0.40 | 0.02-6.60 | 0.5 |
Table 6 Sex-stratified multivariable linear regression: Associations between genotypes and serum biochemical indices in male pediatric participants
| Model 1 | Model 2 | Model 3 | |||||||
| Characteristic | Beta | 95%CI | P value | Beta | 95%CI | P value | Beta | 95%CI | P value |
| Gene | TBA | ||||||||
| 1 | 108 | 3.1-214 | 0.051 | 109 | 2.2-216 | 0.053 | 206 | 69-342 | 0.007 |
| 2 | 30 | -78 to 138 | 0.6 | 29 | -80 to 139 | 0.6 | 105 | -37 to 246 | 0.2 |
| 3 | 92 | -28 to 211 | 0.14 | 91 | -30 to 212 | 0.15 | 176 | 26-326 | 0.031 |
| AST | |||||||||
| 1 | 18 | -6.0 to 42 | 0.2 | 18 | -6.1 to 43 | 0.2 | 55 | 28-82 | < 0.001 |
| 2 | 17 | -7.7 to 42 | 0.2 | 17 | -8.2 to 42 | 0.2 | 51 | 22-79 | 0.002 |
| 3 | 14 | -14 to 41 | 0.3 | 13 | -14 to 41 | 0.3 | 49 | 19-79 | 0.004 |
| ALP | |||||||||
| 1 | -317 | -484 to -150 | < 0.001 | -305 | -463 to -148 | < 0.001 | -349 | -611 to -87 | 0.016 |
| 2 | -262 | -433 to -90 | 0.005 | -271 | -433 to -109 | 0.002 | -293 | -565 to -21 | 0.046 |
| 3 | -354 | -544 to -165 | < 0.001 | -359 | -538 to -181 | < 0.001 | -375 | -662 to -87 | 0.018 |
| Vit A | |||||||||
| 1 | 0.40 | -0.59 to 1.4 | 0.4 | 0.34 | -0.61 to 1.3 | 0.5 | 0.12 | -1.2 to 1.5 | 0.9 |
| 2 | 0.28 | -0.73 to 1.3 | 0.6 | 0.32 | -0.65 to 1.3 | 0.5 | 0.40 | -1.0 to 1.8 | 0.6 |
| 3 | 1.1 | 0.00-2.2 | 0.060 | 1.1 | 0.07-2.2 | 0.046 | 0.94 | -0.55 to 2.4 | 0.2 |
Table 7 Sex-stratified multivariable linear regression: Associations between genotypes and serum biochemical indices in female pediatric participants
| Model 1 | Model 2 | Model 3 | |||||||
| Characteristic | Beta | 95%CI | P value | Beta | 95%CI | P value | Beta | 95%CI | P value |
| Gene | TBA | ||||||||
| 1 | 89 | 28-150 | 0.007 | 89 | 27-152 | 0.008 | 76 | -8.3 to 160 | 0.089 |
| 2 | 13 | -65 to 92 | 0.7 | 13 | -67 to 93 | 0.7 | -1.9 | -96 to 92 | > 0.9 |
| 3 | 104 | 33-175 | 0.007 | 104 | 32-176 | 0.007 | 97 | 0.44-194 | 0.059 |
| GGT | |||||||||
| 1 | -215 | -373 to -56 | 0.012 | -210 | -372 to -48 | 0.015 | -346 | -565 to -128 | 0.004 |
| 2 | -223 | -428 to -19 | 0.039 | -223 | -431 to -16 | 0.041 | -307 | -551 to -64 | 0.020 |
| 3 | -172 | -357 to 13 | 0.076 | -172 | -359 to 15 | 0.079 | -327 | -578 to -76 | 0.016 |
| AFP | |||||||||
| 1 | 1589 | -6335 to 9513 | 0.7 | 2004 | -6132 to 10140 | 0.6 | -1748 | -16919 to 13422 | 0.8 |
| 2 | -273 | -10648 to 10102 | > 0.9 | -253 | -10761 to 10255 | > 0.9 | -1385 | -17234 to 14463 | 0.9 |
| 3 | 11291 | 916-21666 | 0.043 | 11147 | 629-21665 | 0.049 | 9749 | -6415 to 25914 | 0.3 |
| Vit D | |||||||||
| 1 | -34 | -70 to 2.3 | 0.075 | -33 | -70 to 4.3 | 0.092 | -5.9 | -50 to 38 | 0.8 |
| 2 | -9.3 | -56 to 37 | 0.7 | -9.3 | -56 to 38 | 0.7 | -0.01 | -49 to 49 | > 0.9 |
| 3 | -66 | -110 to -21 | 0.007 | -66 | -111 to -21 | 0.007 | -34 | -88 to 19 | 0.2 |
| Vit E | |||||||||
| 1 | -15 | -23 to -7.5 | < 0.001 | -15 | -24 to -7.2 | 0.001 | -22 | -34 to -10 | 0.003 |
| 2 | -8.8 | -19 to 1.2 | 0.10 | -8.8 | -19 to 1.4 | 0.10 | -11 | -22 to -0.48 | 0.060 |
| 3 | -18 | -35 to -0.72 | 0.052 | -18 | -36 to -0.37 | 0.056 | -23 | -42 to -4.8 | 0.027 |
| Fe | |||||||||
| 1 | -34 | -58 to -8.9 | 0.018 | -36 | -62 to -11 | 0.015 | -58 | -100 to -15 | 0.032 |
| 2 | -36 | -68 to -3.8 | 0.045 | -36 | -69 to -3.7 | 0.047 | -44 | -84 to -4.0 | 0.068 |
| 3 | -25 | -72 to 22 | 0.3 | -25 | -73 to 22 | 0.3 | -48 | -106 to 9.4 | 0.15 |
| Thyroid dysfunction | |||||||||
| 1 | 0.06 | 0.00-0.55 | 0.017 | 0.08 | 0.01-0.71 | 0.030 | 0.23 | 0.01-5.14 | 0.3 |
| 2 | 1.00 | 0.07-13.8 | > 0.9 | 1.00 | 0.07-14.0 | > 0.9 | 1.57 | 0.08-41.5 | 0.8 |
| 3 | 0.10 | 0.00-1.20 | 0.094 | 0.17 | 0.01-2.43 | 0.2 | 0.45 | 0.01-16.0 | 0.7 |
- Citation: Wang MF, Chen R, Li J, Cun ZK, Li Q, Jiang HC, Li JW. Genotype-phenotype landscape of Sodium taurocholate cotransporting polypeptide deficiency in Yunnan Province, China: A five-year retrospective, multi-ethnic cohort study. World J Gastrointest Oncol 2026; 18(11): 123971
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123971.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123971